Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Consensus Recommendations on Vaccination in Hemophilia

Publish date:: May 1, 2019

Key clinical point: A group of Italian experts provided 27 consensus statements regarding vaccination in patients with hemophilia.

Major finding: Vaccination in patients with hemophilia should be provided in accordance with the institutional schedule for those without bleeding disorders, but warrants comprehensive planning that addresses specific disease-related factors.

Study details: Evidence-based consensus recommendations provided by an 11-member expert committee.

Disclosures: The study was supported by Sobi. The authors financial affiliations with Bayer, Bioverativ, CSL Behring, Grifols, Kedrion, Novo Nordisk, Pfizer, and several others.

Citation:

Santagostino E et al. Haemophilia. 2019 Apr 16. doi: 10.1111/hae.13756.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Bleeding Disorders

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

Hemochromatosis variants may confer 10-fold higher risk of liver cancer,

Hemophilia, von Willebrand disease do not increase postop complications for ACL reconstruction,

Mouth splints decrease risk of post–dental extraction bleeding in hemophilia,

Low VWF levels or blood group O not linked to intracerebral hemorrhage risk,